Daily non-political popular news in brief.
Stanford study finds transplant patient thrives 2 years after stopping immunosuppressive drugs
01-23-2008 · EurekAlert!Stanford researchers describe a patient's case in a brief report to be published in the Jan. 24 issue of The New England Journal of Medicine on the technique they developed, based on 25 years of research by Samuel Strober, MD, professor of immunology and rheumatology. The journal issue also includes two reports from other research groups, describing their efforts to achieve organ transplantation without long-term immunosuppressive drugs.
Read more »
Keywords: stanford, study, transplant, patient, thrives, stopping, immunosuppressive, drugs, thrive, drug
« Previous | Next »
Similar news on "Stanford study finds transplant patient thrives 2 years after stopping immunosuppressive drugs":
- Antibody reduces incidence of acute rejection in high-risk kidney transplant patients
11-08-2006 · EurekAlert!
Nearly 70 percent of kidney transplant patients get short-term drug therapy initially administered during surgery to help prevent rejection. In the first direct comparison of the two drugs most commonly given to ward off acute kidney rejection, an international study led by Washington University School of Medicine in St. Louis shows that one -- anti-thymocyte globulin -- is superior. The results also suggest the drug could potentially save millions of dollars in health care costs.
Similar news · Read more »
- Study provides hope that some transplant patients could live free of anti-rejection drugs
08-20-2007 · EurekAlert!
People with organ transplants, resigned to a lifetime of antirejection drugs, may now have reason to hope for a respite, say researchers at Lucile Packard Children's Hospital and the Stanford University School of Medicine.
Similar news · Read more »
- Medication costs infrequently addressed when newly prescribed, UCLA study finds
11-08-2006 · EurekAlert!
A new UCLA study has found that physicians discuss cost and aspects of obtaining newly prescribed medications only about one-third of the time during patient/doctor interactions.But questions about pricing and prescription drug insurance coverage are critical -- the high costs of drugs, including out-of-pocket payouts such as co-payments, are linked to patient non-adherence in maintaining their dosage schedules
Similar news · Read more »
- Memantine and Alzheimer's disease
01-10-2008 · EurekAlert!
In a study published in the Journal of Alzheimer's Disease, researchers from the University of Aberdeen report that the drug memantine, used for the treatment of Alzheimer's disease and praised as "the first and only representative of a new class of Alzheimer drugs" works in fact similar to other existing compounds, and is beneficial only in a narrow concentration range. They further indicate that the complex pharmacological profile of memantine requires careful consideration concerning suitable doses and suitable patient groups.
Similar news · Read more »
- Mouse Tests Predict Drug Response In Relapsing Pancreatic Cancer Patients
10-12-2006 · ScienceDaily
By slicing up bits of patient tumors and grafting them into mice, Johns Hopkins Kimmel Cancer Center specialists have figured out how to accurately 'test drive' chemotherapy drugs to learn in advance which drug treatments offer each individual pancreatic cancer patient the best therapeutic journey.
Similar news · Read more »
- Study suggests some drug resistance to influenza B medications
04-03-2007 · EurekAlert!
Use of certain common antiviral drugs during a recent influenza B epidemic in Japan showed the development of viruses with partial resistance to the drugs, according to a study in the April 4 issue of JAMA.
Similar news · Read more »
- Drugs users are increasingly more cautious with needles
05-14-2007 · EurekAlert!
Even though HIV can be well treated these days, drug users are still more cautious about using needles than they used to be. That is the conclusion of Colette Smit following her study into 25 years of HIV in the Netherlands.
Similar news · Read more »
- Nanoparticles hitchhike on red blood cells: a potential new method for drug delivery
06-27-2007 · EurekAlert!
Polymeric nanoparticles are excellent carriers for delivering drugs. However, they are quickly removed from the blood, sometimes in minutes, rendering them ineffective in delivering drugs. This study reports that nanoparticles can be forced to remain in circulation by attaching to red blood cells. Prolonged circulation of nanoparticles in the blood may potentially open new opportunities for the treatment of conditions such as cancer and heart disease.
Similar news · Read more »
- Most children in US hospitals receive medicines off-label
03-05-2007 · EurekAlert!
Nearly four out of five hospitalized children receive medications that have been tested and approved only for adults, according to a study of hundreds of thousands of patient records. This so-called "off-label" use of drugs was thought to be especially common in children, and the new research, the largest-ever U.S. pediatric study, confirms this.
Similar news · Read more »
- Health providers could save billions without compromising health care says drug study
01-17-2007 · EurekAlert!
Switching patients to more cost-effective drugs for cholesterol and blood pressure problems could reduce health budgets by billions without compromising clinical care, according to a study in the January issue of IJCP, the International Journal of Clinical Practice. No adverse events were reported after patients were switched -- the new cholesterol drugs delivered the same results as the previous drug and the new blood pressure drugs delivered improved performance.
Similar news · Read more »
